Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ashwin, Swami"'
Autor:
Stephen Oh, Ruben Mesa, Claire Harrison, Prithviraj Bose, Aaron Gerds, Vikas Gupta, Ashwin Swami, Shanthakumar Tyavanagimatt, Sarah Buckley, Karisse Roman-Torres, Srdan Verstovsek
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ac1996a7693b0bbba66d9ab85cab193
https://doi.org/10.1016/s2152-2650(22)00954-5
https://doi.org/10.1016/s2152-2650(22)00954-5
Autor:
Stephen, Oh, Ruben, Mesa, Claire, Harrison, Prithviraj, Bose, Aaron, Gerds, Vikas, Gupta, Ashwin, Swami, Shanthakumar, Tyavanagimatt, Sarah, Buckley, Karisse, Roman-Torres, Srdan, Verstovsek
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S327
Pacritinib (PAC) is a novel JAK2/IRAK1 inhibitor approved for patients with myelofibrosis (MF) and platelets50×10This analysis included PERSIST-2 patients with platelet count ≤100×10The analysis included 106 patients on PAC 200mg BID, 104 on 400m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76e507a19ff34e51edde1c6f8eef2867
https://doi.org/10.1016/s2152-2650(22)01439-2
https://doi.org/10.1016/s2152-2650(22)01439-2
Autor:
David H. Spodick, Ashwin Swami
Publikováno v:
Clinical cardiology. 26(5)
Pulsus paradoxus has interested physicians for more than a century. Since McGregor's comprehensive New England Journal of Medicine article in 1979,(1) there have been no updated reviews; accordingly, we review pulsus paradoxus based on the clinical a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bed8214d53efaed56c742f7127da2600
https://pubmed.ncbi.nlm.nih.gov/12769248
https://pubmed.ncbi.nlm.nih.gov/12769248